🎉 M&A multiples are live!
Check it out!

Jilin Aodong Valuation Multiples

Discover revenue and EBITDA valuation multiples for Jilin Aodong and similar public comparables like Galapagos, Benevolent AI, and Pharming.

Jilin Aodong Overview

About Jilin Aodong

Jilin Aodong Pharmaceutical Group Co Ltd is engaged in manufacturing of pharmaceuticals. Its products include Anshen Bunao Liquid, Antelope Cough Syrup, Yangxue Yin Oral Liquid, Xinnao Shutong Capsule, Calf Spleen Extract Injection, Xuefu Zhuyu Oral Liquid, and others.


Founded

2000

HQ

China
Employees

29

Website

jlaod.com

Financials

LTM Revenue n/a

LTM EBITDA n/a

EV

$2.5B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Jilin Aodong Financials

Jilin Aodong has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.

In the most recent fiscal year, Jilin Aodong achieved revenue of $475M and an EBITDA of $259M.

Jilin Aodong expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Jilin Aodong valuation multiples based on analyst estimates

Jilin Aodong P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $475M n/a XXX XXX XXX
Gross Profit $166M $202M XXX XXX XXX
Gross Margin 35% NaN% XXX XXX XXX
EBITDA $259M n/a XXX XXX XXX
EBITDA Margin 54% NaN% XXX XXX XXX
Net Profit $245M $245M XXX XXX XXX
Net Margin 52% NaN% XXX XXX XXX
Net Debt $114M $209M XXX XXX XXX

Financial data powered by Morningstar, Inc.

Jilin Aodong Stock Performance

As of April 15, 2025, Jilin Aodong's stock price is CNY 16 (or $2).

Jilin Aodong has current market cap of CNY 18.7B (or $2.6B), and EV of CNY 18.0B (or $2.5B).

See Jilin Aodong trading valuation data

Jilin Aodong Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$2.5B $2.6B XXX XXX XXX XXX n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Jilin Aodong Valuation Multiples

As of April 15, 2025, Jilin Aodong has market cap of $2.6B and EV of $2.5B.

Jilin Aodong's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.

Analysts estimate Jilin Aodong's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Jilin Aodong and 10K+ public comps

Jilin Aodong Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $2.5B XXX XXX XXX
EV/Revenue n/a XXX XXX XXX
EV/EBITDA n/a XXX XXX XXX
P/E n/a XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF n/a XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Jilin Aodong Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Jilin Aodong Valuation Multiples

Jilin Aodong's NTM/LTM revenue growth is n/a

Jilin Aodong's revenue per employee for the last fiscal year averaged $16.4M, while opex per employee averaged $6.8M for the same period.

Over next 12 months, Jilin Aodong's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Jilin Aodong's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Jilin Aodong and other 10K+ public comps

Jilin Aodong Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth n/a XXX XXX XXX XXX
EBITDA Margin n/a XXX XXX XXX XXX
EBITDA Growth n/a XXX XXX XXX XXX
Rule of 40 (SaaS-only) n/a XXX XXX XXX XXX
Revenue per Employee $16.4M XXX XXX XXX XXX
Opex per Employee $6.8M XXX XXX XXX XXX
S&M Expenses to Revenue 27% XXX XXX XXX XXX
G&A Expenses to Revenue 5% XXX XXX XXX XXX
R&D Expenses to Revenue 4% XXX XXX XXX XXX
Opex to Revenue 41% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Jilin Aodong Public Comps

See public comps and valuation multiples for Drug Development & Therapeutics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Benevolent AI XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Jilin Aodong M&A and Investment Activity

Jilin Aodong acquired  XXX companies to date.

Last acquisition by Jilin Aodong was  XXXXXXXX, XXXXX XXXXX XXXXXX . Jilin Aodong acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Jilin Aodong

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Jilin Aodong

When was Jilin Aodong founded? Jilin Aodong was founded in 2000.
Where is Jilin Aodong headquartered? Jilin Aodong is headquartered in China.
How many employees does Jilin Aodong have? As of today, Jilin Aodong has 29 employees.
Is Jilin Aodong publicy listed? Yes, Jilin Aodong is a public company listed on SHE.
What is the stock symbol of Jilin Aodong? Jilin Aodong trades under 000623 ticker.
When did Jilin Aodong go public? Jilin Aodong went public in 1996.
Who are competitors of Jilin Aodong? Similar companies to Jilin Aodong include e.g. Julphar, Benevolent AI, Galapagos, Pharming.
What is the current market cap of Jilin Aodong? Jilin Aodong's current market cap is $2.6B
Is Jilin Aodong profitable? Yes, Jilin Aodong is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.